Relations with ShareholdersThe Directors place great importance on maintaining good communications with both institutional and private investors. The Company reports formally to shareholders twice a year with the publication of its interim and annual reports. More regular communication is provided through the website www.sinclairpharma.com where all press releases are posted. The Executive Directors also present to institutional shareholders and analysts at the time of the interim and full year results. Feedback from these meetings is provided to the Board through the Company’s brokers. Ms P Freer, the Senior Independent Director, is available to shareholders if and when required.
The AGM provides an opportunity to communicate with private and institutional shareholders and the Company welcomes their participation.
|